The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BCMA-directed CART therapy in patients with multiple myeloma and CNS involvement.
 
Mahmoud R. Gaballa
Consulting or Advisory Role - Bristol-Myers Squibb
 
Omar Alexis Castaneda Puglianini
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene/Juno; Legend Biotech
 
Adam D. Cohen
Consulting or Advisory Role - Abbvie; Arcellx; Bristol Meyers Squibb; GlaxoSmithKline; Ichnos Sciences; ITeos Therapeutics; Janssen Oncology; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to CAR T cells and biomarkers of Cytokine Release Syndrome
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Ichnos Sciences; Janssen Oncology; Janssen Oncology
 
Dan T. Vogl
Consulting or Advisory Role - Celgene; CSL Behring; Genentech; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Research Funding - Active Biotech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Karyopharm Therapeutics; Takeda
 
Alfred Chung
Consulting or Advisory Role - Janssen
Research Funding - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Caelum Biosciences (Inst); Cellectis (Inst); Janssen (Inst); k36 Therapeutics (Inst); Merck (Inst)
 
Christopher J. Ferreri
Stock and Other Ownership Interests - AFMD
 
Peter M. Voorhees
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb (Mexico); GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Janssen (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Sanofi
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline
 
Doris K. Hansen
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb/Celgene
 
Krina K. Patel
Consulting or Advisory Role - Abbvie; Arcellx; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Cellectis; Janssen; Karyopharm Therapeutics; Merck; Pfizer; Takeda
Research Funding - Abbvie/Genentech; Allogene Therapeutics; Celgene/Bristol-Myers Squibb; Cellectis; Janssen; Nektar; Precision Biosciences; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb